HG vs ELVN
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
HG · Hamilton Insurance$36.94 ▼ 0.11%
ELVN · Enliven Therapeutics$49.43 ▲ 10.36%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- HG +50.5%
- ELVN +164.2%
Head to head
| Metric | HG | ELVN |
|---|---|---|
| Price | $36.94 | $49.43 |
| Change today | ▼ 0.11% | ▲ 10.36% |
| Market cap | $3.64B | $3.64B |
| Return, 3 months | +6.0% | -16.8% |
| Return, year to date | +41.7% | +221.0% |
| Return, 1 year | +51.6% | +180.4% |
| P/E (TTM) | 7.1 | – |
| P/B | 1.2 | 4.1 |
| P/E percentile vs own 5y | 82nd | 21st |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +21.5% | – |
| Net profit growth (YoY) | +29.3% | -28.2% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 16.8% | – |
| Return on equity | 19.0% | -15.3% |
| Analyst target vs. price | +6.0% | +50.4% |
| Analyst buy share | 67% | 100% |
| RSI (14) | 61 | 64 |
| 30-day volatility | 22.5% | 56.5% |
| Max drawdown, 1 year | -12.7% | -39.0% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ELVN is the largest of the group by market value.
- ELVN has returned the most over the past year.
- HG has been the calmest stock over the last 30 days.